Nosium AB (publ)
Informe acción NGM:NOSIUM B
Capitalización de mercado: SEK 20.0m
Nosium Dirección
Dirección controles de criterios 0/4 Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Daniel Ehdin
Chief Executive Officer (CEO)
Porcentaje del salario del CEO n/a Permanencia del CEO no data Participación del CEO 0.3% Permanencia media de la dirección sin datos Promedio de permanencia en la Junta Directiva sin datos
Actualizaciones recientes de la dirección
CEO & Director recently bought kr51k worth of stock Oct 05
No independent directors Nov 16
CEO & Director recently sold kr1m worth of stock Jun 01
No independent directors Apr 27
CEO & Director recently sold kr110k worth of stock Oct 01
Mostrar todas las actualizaciones
New major risk - Shareholder dilution Sep 13
New major risk - Revenue and earnings growth Dec 13
New minor risk - Financial data availability Dec 03
CEO & Director recently bought kr51k worth of stock Oct 05
New major risk - Share price stability Aug 18
No independent directors Nov 16
Second quarter 2022 earnings released Sep 03
CEO & Director recently sold kr1m worth of stock Jun 01
First quarter 2022 earnings released May 19
No independent directors Apr 27
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 28
Third quarter 2021 earnings released Nov 20
CEO & Director recently sold kr110k worth of stock Oct 01
Second quarter 2021 earnings released Aug 21
First quarter 2021 earnings released May 22
New 90-day low: kr8.90 Feb 20
Full year 2020 earnings released: kr1.38 loss per share (vs kr0.35 loss in FY 2019) Feb 18
Scandinavian Health Innovations AB (publ) (NGM:SHI B) acquired Brandtics AB for SEK 18.5 million. Dec 19
Scandinavian Health Innovations AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 1.6 million. Dec 04
New 90-day high - kr12.00 Aug 28
CEO Mr. Daniel Ehdin serves as Chief Executive Officer and Director of Nosium AB (publ) (formerly known as Scandinavian Health Innovations AB (publ)) (formerly known as Dr Sannas AB (publ)).
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}